Accendra Health, Inc.
ACH
$3.23
$0.072.22%
NYSE
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -11.45% | 1.68% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -11.45% | 1.68% | |||
| Cost of Revenue | -9.32% | 2.84% | |||
| Gross Profit | -13.99% | 0.33% | |||
| SG&A Expenses | -6.58% | 2.77% | |||
| Depreciation & Amortization | 0.00% | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.84% | 7.37% | |||
| Operating Income | -130.85% | -63.03% | |||
| Income Before Tax | -103.81% | -119.28% | |||
| Income Tax Expenses | -764.27% | -25.35% | |||
| Earnings from Continuing Operations | 31.50% | -68.41% | |||
| Earnings from Discontinued Operations | -- | 67.59% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 88.52% | 62.52% | |||
| EBIT | -130.85% | -63.03% | |||
| EBITDA | 9.09% | -57.90% | |||
| EPS Basic | 88.48% | 62.23% | |||
| Normalized Basic EPS | -529.40% | -124.35% | |||
| EPS Diluted | 88.55% | 62.00% | |||
| Normalized Diluted EPS | -529.40% | -124.35% | |||
| Average Basic Shares Outstanding | -0.35% | -0.76% | |||
| Average Diluted Shares Outstanding | -0.35% | -0.76% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||